TACSTD2 and cancer: After treatment with N14 and N152, there was a notable decrease in the number of NCI-N87 cells migrating to the lower chamber, indicating that both N14 and N152 significantly impeded the migration of Trop2-positive cancer cells, with N14 showing superior inhibitory activity (Figure 4E,F).